PTAB Issues Final Written Decisions Finding Claims Of Regene

PTAB Issues Final Written Decisions Finding Claims Of Regeneron's Aflibercept Patents Invalid - Patent

On November 9, 2022, the PTAB issued final written decisions in IPR2021-00880 and IPR2021-00881, filed by Mylan on two Regeneron patents related to aflibercept—U.S. Patent Nos. 9,254,338 and 9,669,069.

Related Keywords

West Virginia , United States , , Northern District , Judge Kleeh , Big Molecule Watch , Mondaq , November 11 , 022 Christopher Cassella , Intellectual Property , Patent ,

© 2025 Vimarsana